Medication info
Clarithromycin 250 mg Tablets

Clarithromycin 250 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Clarithromycin›250mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
[Domestically Available] Yellow oval film-coated tablet with vanilla flavor [For Export] Yellow rectangular film-coated tablet
Packaging
Domestic Use - 30 tablets/bottle, Domestic Use - 100 tablets/bottle, For Export - 20 tablets/box [(10 tablets/PTPX2)], For Export - 100 tablets/box [(10 tablets/PTPX10)]
Approval status
Active

MFDS item code 201206831 · Approved 2012.09.18 · Insurance code 698502320

Summary

Main use
Treatment of infections (respiratory, skin, and mycobacterial infections) and eradication of Helicobacter pylori in duodenal ulcers
Who takes it
Adults · Children
Adult dose
○ Adults: The usual dose of clarithromycin is 250mg (potency) twice daily. For severe infections, administer 500mg (potency) twice daily. The usual treatment duration is 7~14 days. In patients with renal impairment and creatinine clearance of 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) twice daily. Do not administer to these patients for more than 14 days. ○ Mycobacterial infections: Administer 500mg (potency) of this medicine twice daily. In this case, it must be administered concomitantly with other antimycobacterial agents such as ethambutol, clofazimine, or rifampin. ○ Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer 500mg (potency) of this medicine 3 times daily for 14 days together with omeprazole 40mg once daily, followed by omeprazole 40mg once daily for an additional 14 days. That is, administer clarithromycin 500mg (potency) per dose 3 times daily for 14 days (days 1~14), and omeprazole 40mg once daily for 28 days (days 1~28).
Child dose
Children aged 12 years and older: Same as adults. For children under 12 years, use clarithromycin dry syrup.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of infections (respiratory, skin, and mycobacterial infections) and eradication of Helicobacter pylori in duodenal ulcers

  • Bronchitis
  • pneumonia
  • pharyngitis
  • sinusitis
  • skin and soft tissue infections
  • mycobacterial infections
  • duodenal ulcers
View approved original text

This medication is used to treat lower respiratory infections such as bronchitis and pneumonia, upper respiratory infections like pharyngitis and sinusitis, as well as skin and soft tissue infections. It is also effective against mycobacterial infections caused by Mycobacterium avium and intracellular. In patients with duodenal ulcers, this medication is used to eradicate Helicobacter pylori. It has a broad antibacterial action against various bacteria, helping to improve infection symptoms. This medication contributes to the recovery of patients' health by treating several types of bacterial infections.

How to take

Adult dose

○ Adults: The usual dose of clarithromycin is 250mg (potency) twice daily. For severe infections, administer 500mg (potency) twice daily. The usual treatment duration is 7~14 days. In patients with renal impairment and creatinine clearance of 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) twice daily. Do not administer to these patients for more than 14 days. ○ Mycobacterial infections: Administer 500mg (potency) of this medicine twice daily. In this case, it must be administered concomitantly with other antimycobacterial agents such as ethambutol, clofazimine, or rifampin. ○ Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer 500mg (potency) of this medicine 3 times daily for 14 days together with omeprazole 40mg once daily, followed by omeprazole 40mg once daily for an additional 14 days. That is, administer clarithromycin 500mg (potency) per dose 3 times daily for 14 days (days 1~14), and omeprazole 40mg once daily for 28 days (days 1~28).

Child dose

Children aged 12 years and older: Same as adults. For children under 12 years, use clarithromycin dry syrup.

Precautions

This medication should not be used by patients who are allergic to certain components. Those with a history of allergic reactions to clarithromycin or similar antibiotics should also avoid administration. Patients with a history of arrhythmias or prolonged QT interval should be cautious as it may pose risks. It is also unsafe for patients with very poor liver function or severely impaired kidney function to use this medication. Women who are pregnant or breastfeeding should not take this medication. This medication can interact with several other drugs; please inform your healthcare provider of any medications you are currently taking. Caution is particularly needed when used in conjunction with medications that can affect the heart, certain antibiotics, antidiabetics, and immunosuppressants. If any abnormal symptoms such as allergic reactions, gastrointestinal disturbances, breathing difficulties, skin rash, or hearing abnormalities occur during treatment, consult your healthcare provider immediately. Long-term or high-dose use may lead to hearing damage or tinnitus; if symptoms arise, treatment should be stopped. Elderly patients or those with impaired liver or kidney function may require dosage adjustments, so they should follow their healthcare provider's instructions. This medication may require caution during driving or operating machinery, so effects should be monitored while taking it. Overdose may cause gastrointestinal disturbances or psychiatric symptoms, so it is essential to adhere to the prescribed dosage and administration. During treatment with this medication, it is crucial to take it consistently for the prescribed duration to prevent antibiotic resistance.

Side effects

shock, anaphylactic symptoms, respiratory distress, convulsions, flushing, rash, itching, hives, skin flushing, angioedema, joint swelling, drug rash, abdominal distension, nausea, vomiting, dyspepsia, abdominal pain, malaise, bloating, diarrhea, oral erosion, upper abdominal pain, thirst, tooth discoloration, pancreatitis, increased amylase, taste disturbance, loss of appetite, constipation, discoloration of stool, membrane colitis, hemorrhagic colitis, fever, cough, respiratory distress, abnormal chest X-ray, eosinophilia, eosinophilic lung infiltration, interstitial pneumonia, chronic bronchitis, acute maxillary sinusitis, eosinophilia, thrombocytopenia, pancytopenia, hemolytic anemia, leukopenia, agranulocytosis, dizziness, depression, taste loss, smell loss, anxiety, insomnia, nightmares, tinnitus, confusion, disorientation, hallucinations, psychosis, derealization, convulsions, tremors, numbness, behavioral changes, manic behavior, Stevens-Johnson syndrome, toxic epidermal necrolysis, allergic purpura, drug rash accompanied by eosinophilia and systemic symptoms, jaundice, hepatocellular hepatitis, cholestatic hepatitis, increased liver enzymes, liver dysfunction, liver failure, fulminant hepatitis, elevated AST, elevated ALT, elevated γ-GTP, elevated LDH, elevated ALP, increased total bilirubin, elevated serum creatinine, elevated BUN, interstitial nephritis, renal failure, rhabdomyolysis, glossitis, stomatitis, oral candidiasis, QT prolongation, ventricular tachycardia, Torsades de pointes, fatigue, headache, taste disturbance, hearing loss, paresthesia, arthralgia, myalgia, olfactory dysfunction, tinnitus, hearing impairment, hypoglycemia, tinnitus, hearing loss, vomiting, nausea, abdominal pain, purpuric rash, acute generalized exanthematous pustulosis, leukopenia, neutropenia, thrombocytosis, agranulocytosis, thrombocytopenia, anaphylactic reaction, angioedema, decreased appetite, insomnia, nervousness, auditory sensitivity, confusion, abnormal dreams, muscle cramps, musculoskeletal rigidity, myopathy, vasodilation, angioedema, elevated serum creatinine, elevated serum urea, nephritis, injection site phlebitis, injection site pain, injection site inflammation, fever, asthenia, chest pain, chills, fatigue, abnormal albumin-globulin ratio, elevated serum alkaline phosphatase, elevated serum lactate dehydrogenase, increased international normalized ratio, prolonged prothrombin time, urine color abnormalities, esophagitis, gastroesophageal reflux disease, gastritis, rectal pain, tongue discoloration, hyperhidrosis, acne, Henoch-Schonlein purpura

Not everyone experiences these, and they can vary from person to person.

Storage

If for domestic use, this medication should be stored in an airtight container that does not allow air in, at room temperature between 1°C and 30°C. For export products, store in a sealed container in a dry place away from moisture, shielding it from light to preserve its efficacy and prevent deterioration.

Appearance and packaging

Appearance

[Domestically Available] Yellow oval film-coated tablet with vanilla flavor [For Export] Yellow rectangular film-coated tablet

Package unit

Domestic Use - 30 tablets/bottle, Domestic Use - 100 tablets/bottle, For Export - 20 tablets/box [(10 tablets/PTPX2)], For Export - 100 tablets/box [(10 tablets/PTPX10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.